14-day Premium Trial Subscription Try For FreeTry Free

Conformis Announces Full Commercial Launch of Imprint™

12:00pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) Conformis’ Imprint™ knee system introduces the new “Made-to

Conformis, Inc. Announces Settlement of Medacta Patent Litigation

09:15pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Conformis Settles Medacta Litigation Related to Patient-Specific Instruments Conformis Settles Medacta Litigation Related to Patient-Specific Instruments
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac

ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates

11:25pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Conformis, Inc. (NASDAQ:CFMS ) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participan
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The arrival of the seventh annual UBS global real estate bubble report rings different, coming at the start of a period of retreat rather than during a wave of excess.
A new research paper circulated by the National Bureau of Economic Research asks a fascinating question -- which region will come to dominate the world economy?

Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022

08:30pm, Wednesday, 05'th Oct 2022 GlobeNewswire Inc.
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it wi
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Wednesday after recording sharp losses on Tuesday following the release of inflation data for August. All the three major

BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday

09:19am, Wednesday, 14'th Sep 2022 Benzinga
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects BRP Inc. (NASDAQ: DOOO) to report quarterly
New design adds increasingly more common tri-taper femoral stem design and direct anterior approaches to the expanding Conformis family of Personalized Total Hip Arthroplasty implants New design adds
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE